Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
British Journal of Cancer
|
June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
A Bamias, K Tzannis, B Beuselinck, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Sarcoma
|
April 18, 2020
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis
P Schöffski, I Timmermans, D Hompes, et al.
Genes and Immunity
|
March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patients
I Roodhooft, L Kinget, G Mammone, et al.
Sarcoma
|
February 25, 2021
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis"
P Schöffski, I Timmermans, D Hompes, et al.
British Journal of Cancer
|
November 4, 2015
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
B Beuselinck, J Jean-Baptiste, G Couchy, et al.
British Journal of Cancer
|
March 7, 2013
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
B Beuselinck, A Karadimou, D Lambrechts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
N Agarwal, J Brugarolas, P Ghatalia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
T van Cann, T Loyson, A Verbiest, et al.
ESMO Open
|
June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium
K Takemura, T Yuasa, A Lemelin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
British Journal of Cancer
|
June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
A Bamias, K Tzannis, B Beuselinck, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort
S Thijssen, H Wildiers, K Punie, et al.
Sarcoma
|
April 18, 2020
Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis
P Schöffski, I Timmermans, D Hompes, et al.
Genes and Immunity
|
March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patients
I Roodhooft, L Kinget, G Mammone, et al.
Sarcoma
|
February 25, 2021
Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis"
P Schöffski, I Timmermans, D Hompes, et al.
British Journal of Cancer
|
November 4, 2015
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
B Beuselinck, J Jean-Baptiste, G Couchy, et al.
British Journal of Cancer
|
March 7, 2013
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
B Beuselinck, A Karadimou, D Lambrechts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
N Agarwal, J Brugarolas, P Ghatalia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
T van Cann, T Loyson, A Verbiest, et al.
ESMO Open
|
June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium
K Takemura, T Yuasa, A Lemelin, et al.
Page
of 3